| Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model K Anthony-Gonda, A Bardhi, A Ray, N Flerin, M Li, W Chen, ... Science translational medicine 11 (504), eaav5685, 2019 | 101 | 2019 |
| Application of Novel T Cell Immunotherapeutics to Drive Antigen-Specific Activation, Expansion, and Differentiation of CD19 Chimeric Antigen Receptor T Cells (CAR T-cells) HG Moriah Rabin, Mengyan Li, Scott Garforth, Jacqueline Marino, Jian Hua ... Blood 136 (Supplement 1), 34-35, 2020 | 1 | 2020 |
| Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo S Zeigler, A Woodham, M Li, E Zeyang, S Kolifrath, M Rashidian, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| T cell receptor–targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice M Li, S Garforth, K O'Conner, H Su, D Lee, A Celikgil, RJ Chaparro, ... Journal of Clinical Investigation, 2021 | | 2021 |
| Weaponizing the Immune System to Fight Infectious Diseases: Developing Immunotherapeutics to Amplify and Reinvigorate Potent HIV and CMV-Specific CD8+ T Cell Responses M Li Yeshiva University, 2020 | | 2020 |
